Oncology Clinical Trials in Canton, OH

As of August 2026, 54 paid clinical trials are recruiting for Oncology in Canton, Ohio. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

54 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Canton, OH.

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for Advanced Malignant Solid Neoplasm

Sites in Canton, Beachwood +429 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: All ages

Code: NCT05564377·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for Lung Non-Small Cell Carcinoma

Sites in Canton, Columbus +264 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06498635·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Sites in Canton, Akron +144 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06532279·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

Sites in Canton, Columbus +59 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06649812·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for Prostate Adenocarcinoma

Sites in Canton, Akron +397 more locations

Sponsor: NRG Oncology

Sex: Male·Age: 18+

Code: NCT05946213·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

for Head and Neck Squamous Cell Carcinoma

Sites in Canton +168 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT06992427·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Molecular Genetics Studies of Cancer Patients and Their Relatives

for Malignant Neoplasm

Sites in Canton +34 more locations

Sponsor: City of Hope Medical Center

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT04185935·Recruiting·Listed Dec 2019

Apply to this trial

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for Lung Non-Small Cell Carcinoma

Sites in Canton, Columbus +241 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Integrated Cancer Repository for Cancer Research

for Pancreatic Cancer

Sites in Canton, Alliance +40 more locations

Sponsor: University of Nebraska

Sex: All·Age: 19 - 110·Accepts healthy volunteers

Code: NCT02012699·Recruiting·Listed Dec 2013

Apply to this trial

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

for Non Small Cell Lung Cancer

Drug: Osimertinib

Sites in Canton, Troy +144 more locations

Sponsor: PrECOG, LLC.

Sex: All·Age: 18+

Code: NCT06538038·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for Neoplasms, Colorectal

Sites in Canton +3 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT07213609·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

DESTINY-PANTUMOUR04

for Adenocarcinoma (NOS)

Sites in Canton, Maumee +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT07124000·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for Multiple Myeloma

Sites in Canton +10 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05714839·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

for Myelodysplastic Syndromes

Sites in Canton +5 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06847867·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Conditions in Oncology (Canton, OH)

Non-small cell lung cancer (NSCLC)· 12 Solid tumor· 9 Breast cancer· 8 Cancer (any)· 6 Ovarian cancer· 5 Multiple myeloma· 5 Lung cancer· 3 Small cell lung cancer· 3 Colorectal cancer· 3 Prostate cancer· 3 Endometrial cancer· 3 Myelodysplastic syndromes (MDS)· 3 Non-Hodgkin lymphoma· 3 Head and neck cancer· 3 Pancreatic cancer· 2 Esophageal cancer· 2 Liver cancer· 2 Bladder cancer· 2 Kidney cancer· 2 Myelofibrosis· 2 Hematologic malignancy· 2 Melanoma· 2 Thyroid cancer· 2 Sarcoma· 2 Metastatic breast cancer· 1 Triple-negative breast cancer· 1 HER2-negative breast cancer· 1 Colon cancer· 1 Rectal cancer· 1 Gastric cancer· 1 Cervical cancer· 1 Acute myeloid leukemia (AML)· 1 Chronic lymphocytic leukemia (CLL)· 1 Chronic myelomonocytic leukemia· 1 Leukemia (other)· 1 Diffuse large B-cell lymphoma (DLBCL)· 1 Follicular lymphoma· 1 Mantle cell lymphoma· 1 Burkitt lymphoma· 1 Skin cancer· 1 Mesothelioma· 1 Neuroendocrine tumors· 1